Corifollitropin alfa
Elonva (corifollitropin alfa) is a protein pharmaceutical. Corifollitropin alfa was first approved as Elonva on 2010-01-25. It has been approved in Europe to treat assisted reproductive techniques and ovulation induction.
| Trade Name | Elonva |
|---|---|
| Common Name | Corifollitropin alfa |
| Indication | assisted reproductive techniques, ovulation induction |
| Drug Class | Tricyclic compounds; atropine derivatives |
